QUILYPSO
LIVE

Serial Number

79274098

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Oct 21, 2019

Add to watchlist:

No watchlists yet
View on USPTO

QUILYPSO Trademark

Serial Number: 79274098 • Registration: 6132689

QUILYPSO is a trademark filed by NOVARTIS AG on October 21, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,172 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

October 21, 2019

Registration Date

August 25, 2020

Published for Opposition

June 9, 2020

Cancellation Date

September 21, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 17, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Apr 17, 2023 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 23, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Dec 11, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 11, 2020 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 25, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 25, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 7, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 15, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 14, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 14, 2020 TROA
REFUSAL PROCESSED BY IB
Feb 14, 2020 RFNT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 29, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 29, 2020 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 25, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jan 24, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 29, 2019 RFCR
NON-FINAL ACTION WRITTEN
Dec 28, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 23, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 21, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 16, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 12, 2019 SDRC